What moved NSB.AX stock higher pre-market today?

NSB.AX stock rose on heavy volume of 5,803,773 shares versus average 213,564. The move looks volume-driven, likely from retail interest or short covering rather than a formal ASX announcement.

What are the key valuation metrics for NSB.AX stock?

Key metrics: price A$0.165, market cap A$38,246,206, EPS -0.01, PE -11.50, and price-to-book about 0.99. The company is pre-revenue with cash per share A$0.0497.

How does Meyka AI rate NSB.AX stock?

Meyka AI rates NSB.AX with a score out of 100: 66.21, Grade B, suggestion HOLD. The grade uses benchmarks, sector comparison, growth and analyst data. Grades are not guarantees.

What is the short-term trading outlook for NSB.AX stock?

Short-term outlook is volatile. Technicals show RSI 53.91 and overbought CCI and MFI. Watch support A$0.145 and resistance near the year high A$0.26. Trade with stop-loss rules.

AU Stocks

NSB.AX up 43% pre-market 14 Jan 2026: NeuroScientific Biopharma volume spike

ByHuzaifa Zahoor January 13, 2026January 13, 2026

NSB.AX stock opened the pre-market session sharply higher after a large volume surge, trading at A$0.165 on 14 Jan 2026. The move shows a +43.48% change from the prior close and intraday range between A$0.145 and A$0.175. Volume is elevated at 5,803,773 shares versus an average of 213,564, signaling outsized retail or short-covering interest ahead of clinical or corporate catalysts.